Evidence map›Paper›PMID 30615896›Full record

Trial reportOphthalmology2019

A Randomized Clinical Trial of Immediate versus Delayed Glasses for Moderate Hyperopia in 1- and 2-Year-Olds.

Pediatric Eye Disease Investigator Group, Marjean T Kulp, Jonathan M Holmes, Trevano W Dean, Donny W Suh, Raymond T Kraker, David K Wallace, David B Petersen, Susan A Cotter, Ruth E Manny and 7 more

Registry-linked trialOpen access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01515475 (Glasses Versus Observation for Moderate Hyperopia in Young Children), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01515475 nacompletednot on this map

Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1)

TypeinterventionalSponsorJaeb Center for Health ResearchRan2012 to 2018Enrolled249ConditionsHyperopiaArmsGlasses
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. How Do Most Young Moderate Hyperopes Avoid Strabismus?Investigative ophthalmology & visual science · 2023
    Article
  3. Refractive prescribing for preschool children by optometrists in England.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 2 countries.

Pediatric Eye Disease Investigator Group
Marjean T KulpCollege of Optometry, The Ohio State University, Columbus, Ohio. Electronic address: pedig@jaeb.org.
Jonathan M HolmesMayo Clinic, Rochester, Minnesota.
Trevano W DeanJaeb Center for Health Research, Tampa, Florida.
Donny W SuhUniversity of Nebraska Medical Center, Omaha, Nebraska.
Raymond T KrakerJaeb Center for Health Research, Tampa, Florida.
David K WallaceIndiana University, Indianapolis, Indiana.
David B PetersenRocky Mountain Eye Care Associates, Salt Lake City, Utah.
Susan A CotterSouthern California College of Optometry at Marshall B. Ketchum University, Fullerton, California.
Ruth E MannyUniversity of Houston College of Optometry, Houston, Texas.
Rosanne SupersteinCentre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
Tawna L RobertsByers Eye Institute, Stanford University, Palo Alto, CA.
John M AvalloneOphthalmology Associates of Greater Annapolis, Arnold, Maryland.
Deborah R FishmanPediatric Eye Associates, Wilmette, Illinois.
S Ayse ErzurumEye Care Associates, Inc., Poland, Ohio.
David A LeskeMayo Clinic, Rochester, Minnesota.
Alex ChristoffWilmer Eye Institute, Baltimore, Maryland.
Eye Care Associates · USJaeb Center for Health Research · USMayo Clinic · USCentre Hospitalier Universitaire Sainte-Justine · CAIndiana University – Purdue University Indianapolis · USMarshall B. Ketchum University · USNational Eye Institute · USOphthalmology Associates (United States) · USStanford University · USThe Ohio State University · USUniversity of Houston · USUniversity of Nebraska Medical Center · US

Funding

Pediatric Eye Disease Investigator Group Coordinating CenterU10EY011751 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI KRAKER, RAYMOND · 1997 to 2018
$75.2M
Pediatric Eye Disease Investigator Group NetworkUG1EY011751 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI Raymond Kraker, Stacy Pineles · 2019 to 2026
$53.7M
Pediatric Eye Disease Investigator Group: Chair's OfficeU10EY018810 · NEI · MAYO CLINIC ROCHESTER · PI HOLMES, JONATHAN M · 2009 to 2013
$3.5M
PEDIATRIC EYE DISEASE INVESTIGATOR GROUP: CHAIR'S OFFICEU10EY023198 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI WALLACE, DAVID K · 2014 to 2018
$1.4M
NEI NIH HHS U10 EY011751NEI NIH HHS U10 EY018810NEI NIH HHS U10 EY023198NEI NIH HHS UG1 EY011751
6 · The paper itself

Abstract

purposeTwo strategies were compared for managing moderate hyperopia without manifest strabismus among 1- and 2-year-old children: (1) immediate prescription of glasses versus (2) observation without glasses unless reduced distance visual acuity (VA), reduced stereoacuity, or manifest strabismus.

designProspective randomized clinical trial.

participantsA total of 130 children aged 1 to 2 years with hyperopia between +3.00 diopters (D) and +6.00 D spherical equivalent (SE) in at least 1 eye, anisometropia ≤1.50 D SE, and astigmatism ≤1.50 D based on cycloplegic refraction and no manifest strabismus.

methodsParticipants were randomly assigned to glasses (1.00 D less than full cycloplegic hyperopia) versus observation and followed every 6 months for 3 years. Glasses were prescribed to those assigned to observation if they met prespecified deterioration criteria of distance VA or near stereoacuity below age norms, or development of manifest strabismus.

main outcome measuresAt the 3-year primary outcome examination, participants were classified as failing the randomized management regimen if distance VA or stereoacuity was below age norms or manifest strabismus was observed (each with and without correction in trial frames, confirmed by masked retest, irrespective of whether deterioration had occurred previously), or if strabismus surgery had been performed.

resultsOf the 106 participants (82%) completing the 3-year primary outcome examination, failure occurred in 11 (21%) of 53 in the glasses group and 18 (34%) of 53 in the observation group (difference = -13%; 95% confidence interval [CI], -31 to 4; P = 0.14). Sixty-two percent (95% CI, 49-74) in the observation group and 34% (95% CI, 23-48) in the glasses group met deterioration criteria (requiring glasses if not wearing).

conclusionsFor 1- and 2-year-olds with uncorrected moderate hyperopia (+3.00 D to +6.00 D SE), our estimates of failure, after 3 years of 6-month follow-ups, are inconclusive and consistent with a small to moderate benefit or no benefit of immediate prescription of glasses compared with careful observation (with glasses only if deteriorated).

Indexed as

EyeglassesAnisometropiaAstigmatismChild, PreschoolDepth PerceptionFemaleFollow-Up StudiesHumansHyperopiaInfantMalePatient CompliancePrescriptionsProspective StudiesTime-to-TreatmentVision Tests

Identifiers

PMID30615896
PMCPMC6534446
OpenAlexW2908037172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.